Cannabis Strategic Ventures (OTC: NUGS) this morning
announced that it has entered a partnership with Feldmann Nagel Cantafio
Margulis, PLLC, a boutique law firm, under which the firm will act as strategic
advisors for national and international cannabis compliance matters. Formed in
2004 by Charles Feldmann and David Nagel, the firm has extensive cannabis
compliance expertise throughout the United States, Israel, and the
international cannabis marketplace. Feldmann will lead the legal team on
matters associated with cannabis enforcement, licensing, federal risk
mitigation and compliance related issues.
“Cannabis Strategic Ventures is proud to partner with
Charles Feldmann and the Feldmann Nagel Cantafio Margulis team for all cannabis
compliance related to cultivation, distribution, retail matters for our
brands,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release.
“The ever-evolving regulatory landscape at the state and national levels, and
the increasing number of countries implementing cannabis-friendly legislations,
makes it became critically important to have reputable experts on cannabis
enforcement, licensing, federal risk mitigation on our team.”
To view the full press release, visit http://ibn.fm/PJCPz
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is a Los Angeles based firm that
incubates, develops and partners with category leaders within the cannabis
sector. The Firm’s NUGS brand experience provides mentorship and a range of
essential services to emerging and existing Cannabis consumer brands. The
company recently completed a name and symbol change from Cascade Energy, Inc.
Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter
Market with the stock symbol NUGS. For more information, visit the company’s
website at www.CannabisStrategic.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets, these
posts are designed to inform you on the latest happenings of our clients and
other publicly traded companies on our radar. From earnings, acquisitions and
agreements to conference attendance and clinical study results, our news breaks
keep you up-to-date with the day’s top movers. MissionIR is primarily focused
on strategic communications. We have executed countless communications programs
to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
